Topics

FDA Requests Market Withdrawal of Belviq Due to Cancer Risk

14:00 EST 14 Feb 2020 | Drugs.com

FRIDAY, Feb. 14, 2020 -- A clinical trial of the weight-loss drug Belviq (lorcaserin) shows an association with an increased risk for cancer, and the U.S. Food and Drug Administration is requesting that its maker withdraw the drug from the U.S....

Original Article: FDA Requests Market Withdrawal of Belviq Due to Cancer Risk

NEXT ARTICLE

More From BioPortfolio on "FDA Requests Market Withdrawal of Belviq Due to Cancer Risk"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...